News
ZBH
94.97
-0.67%
-0.64
Zimmer Biomet Holdings Price Target Cut to $100.00/Share From $104.00 by Barclays
Dow Jones · 2h ago
Zimmer Biomet Holdings Is Maintained at Underweight by Barclays
Dow Jones · 2h ago
Barclays Maintains Underweight on Zimmer Biomet Holdings, Lowers Price Target to $100
Benzinga · 2h ago
Zimmer Biomet price target lowered to $100 from $104 at Barclays
TipRanks · 5h ago
Barclays Sticks to Their Sell Rating for Zimmer Biomet Holdings (ZBH)
TipRanks · 6h ago
Enovis: Valuation Is Too Low, But Needs To Differentiate On Growth
Seeking Alpha · 7h ago
Zimmer Biomet participates in a conference call with JPMorgan
TipRanks · 23h ago
Zimmer Biomet Holdings Price Target Raised to $98.00/Share From $94.00 by Citigroup
Dow Jones · 1d ago
Zimmer Biomet Holdings Is Maintained at Neutral by Citigroup
Dow Jones · 1d ago
Zimmer Biomet Holdings Is Maintained at Equal-Weight by Wells Fargo
Dow Jones · 1d ago
Zimmer Biomet Holdings Price Target Raised to $98.00/Share From $93.00 by Wells Fargo
Dow Jones · 1d ago
Wells Fargo Maintains Equal-Weight on Zimmer Biomet Holdings, Raises Price Target to $98
Benzinga · 1d ago
Zimmer Biomet price target raised to $89 from $86 at UBS
TipRanks · 1d ago
RBC Capital Remains a Buy on Zimmer Biomet Holdings (ZBH)
TipRanks · 1d ago
Analysts Have Conflicting Sentiments on These Healthcare Companies: Exelixis (EXEL), Edwards Lifesciences (EW) and Zimmer Biomet Holdings (ZBH)
TipRanks · 1d ago
Zimmer Biomet price target raised to $98 from $94 at Citi
TipRanks · 1d ago
Zimmer Biomet (ZBH) Margin Compression And One Off Loss Test Bullish Growth Narrative
Simply Wall St · 1d ago
Zimmer Biomet Stock: Is Wall Street Bullish or Bearish?
Barchart · 1d ago
Zimmer Biomet Earnings Call Balances Growth and Risk
TipRanks · 1d ago
Analysts Have Conflicting Sentiments on These Healthcare Companies: Zimmer Biomet Holdings (ZBH) and OrganiGram Holdings (OGI)
TipRanks · 1d ago
More
Webull provides a variety of real-time ZBH stock news. You can receive the latest news about Zimmer Biomet through multiple platforms. This information may help you make smarter investment decisions.
About ZBH
Zimmer Biomet Holdings, Inc. is a global medical technology company. It designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; CMFT; surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. Its segments include Americas, EMEA, and Asia Pacific. Its products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Its knee brands include the Persona Knee, NexGen Knee Implants, Vanguard Knee and Oxford Partial Knee. Its hip brands include the Taperloc Hip System, Avenir Complete Hip System, Arcos Modular Hip System and G7 Acetabular System. It also focused on a suite of orthopedic robotics, enabling solutions and analytics to address the needs of surgeons pre-, intra- and post-operatively. Its portfolio features imageless robotics through its ROSA Robotics platform.